237 related articles for article (PubMed ID: 33461296)
1. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.
d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M
Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296
[TBL] [Abstract][Full Text] [Related]
2. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
4. Stabilizing Unstable Amorphous Menthol through Inclusion in Mesoporous Silica Hosts.
Cordeiro T; Castiñeira C; Mendes D; Danède F; Sotomayor J; Fonseca IM; Gomes da Silva M; Paiva A; Barreiros S; Cardoso MM; Viciosa MT; Correia NT; Dionisio M
Mol Pharm; 2017 Sep; 14(9):3164-3177. PubMed ID: 28836790
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
6. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
7. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
8. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
9. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
10. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
[TBL] [Abstract][Full Text] [Related]
11. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
[TBL] [Abstract][Full Text] [Related]
12. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
13. Solid State NMR Characterization of Ibuprofen:Nicotinamide Cocrystals and New Idea for Controlling Release of Drugs Embedded into Mesoporous Silica Particles.
Skorupska E; Kaźmierski S; Potrzebowski MJ
Mol Pharm; 2017 May; 14(5):1800-1810. PubMed ID: 28403609
[TBL] [Abstract][Full Text] [Related]
14. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.
Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H
Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669
[TBL] [Abstract][Full Text] [Related]
15. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous Silica as a Drug Delivery System for Naproxen: Influence of Surface Functionalization.
Žid L; Zeleňák V; Almáši M; Zeleňáková A; Szücsová J; Bednarčík J; Šuleková M; Hudák A; Váhovská L
Molecules; 2020 Oct; 25(20):. PubMed ID: 33076274
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures.
Minecka A; Tarnacka M; Jurkiewicz K; Hachuła B; Wrzalik R; Kamiński K; Paluch M; Kamińska E
Mol Pharm; 2021 Jan; 18(1):347-358. PubMed ID: 33355470
[TBL] [Abstract][Full Text] [Related]
18. Evidence of Strong Guest-Host Interactions in Simvastatin Loaded in Mesoporous Silica MCM-41.
Cordeiro T; Matos I; Danède F; Sotomayor JC; Fonseca IM; Corvo MC; Dionísio M; Viciosa MT; Affouard F; Correia NT
Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242562
[TBL] [Abstract][Full Text] [Related]
19. Oral Drug Delivery Systems Based on Ordered Mesoporous Silica Nanoparticles for Modulating the Release of Aprepitant.
Christoforidou T; Giasafaki D; Andriotis EG; Bouropoulos N; Theodoroula NF; Vizirianakis IS; Steriotis T; Charalambopoulou G; Fatouros DG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672949
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
